HIV/AIDS Grant — 2024-2026 Allocation

Program Overview

The HIV/AIDS grant supports Rwanda's national response through a combination of prevention, testing, treatment, and care services. Key interventions include antiretroviral therapy (ART) scale-up, prevention of mother-to-child transmission (PMTCT), and targeted services for key and vulnerable populations.

Key Targets

• Maintain 95% ART coverage among people living with HIV
• Achieve 98% PMTCT coverage nationwide
• Reach 85% of key populations with prevention services
• Reduce new HIV infections by 30% compared to 2023 baseline

Implementation Partners

Rwanda Biomedical Centre serves as the Principal Recipient, coordinating implementation with district health facilities, civil society organizations, and community health workers across all 30 districts.